HOME >> MEDICINE >> NEWS
Ductal lavage may not detect breast cancer, study finds

Ductal lavage is not an effective method for detecting breast cancer, according to a new study in the October 20 issue of the Journal of the National Cancer Institute.

Ductal lavage--a method used to collect cells from the milk ducts of the breast--has been proposed as a screening tool for cancer detection because ducts that yield fluid were thought to be more likely to contain cancer cells. Interest in the procedure was spurred by a study in which ductal lavage detected cancer in four of 11 women who had shown no previous evidence of a malignancy.

To determine the sensitivity and specificity of ductal lavage in the presence of known breast cancer, Seema A. Khan, M.D., of the Lynn Sage Comprehensive Breast Center and Northwestern Memorial Hospital in Chicago, and colleagues conducted a pilot study in which ductal lavage was performed prior to mastectomy on 44 breasts from 32 women with known cancer and on eight breasts from seven women undergoing prophylactic mastectomy.

The researchers found poor agreement between a cytologic analysis of the cells from ductal lavage and results from looking at breast tissue under the microscope. In breasts with cancer, ductal lavage was able to detect only about half of the cancers, possibly because ducts that contain cancer failed to yield fluid or yielded cells classified as benign or mildly atypical. In addition, ducts that produced fluid did not appear to be related to the cancer in about half of the cancer-containing breasts.

"Although further studies are warranted in women with early lesions, our results and those of others indicate that ductal lavage should not be recommended to high-risk women as a technique to detect cancer earlier than imaging modalities," the authors write.

In an editorial, Carol J. Fabian, M.D., of the University of Kansas Medical Center in Kansas City, and colleagues review several other ongoing studies that are attempting to evaluate the utility of duct
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
19-Oct-2004


Page: 1 2

Related medicine news :

1. Ductal lavage may not detect breast cancer
2. Margin Width The Key To Control Of Ductal Carcinoma In Situ Of The Breast
3. Implanted devices detect high-risk heart failure patients
4. CAD detects breast cancers that are most challenging to detect
5. New substance that improves the photodetection of bladder cancer gains market approval
6. Genetic amplification (NAAT) test detects HIV more effectively than standard tests in urban study
7. OHSU scientists develop MRI approach to improve breast cancer detection
8. New test improves detection of bladder cancer
9. Faster, less expensive test proven more effective in detecting bladder cancer
10. Test could improve detection of prion disease in humans
11. A new method for early detection of disease outbreaks

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ductal lavage may not detect breast cancer study finds

(Date:10/20/2014)... York, NY (PRWEB) October 20, 2014 ... based non-profit organization that helps New Yorkers living ... positive changes toward health, housing, recovery and self-sufficiency. ... have transformed the local community through their tireless ... Director, Marc Shapses , has been selected ...
(Date:10/20/2014)... Ga. (PRWEB) October 20, 2014 ... and relationship-marketing firm, announced today that William H. ... named the 2014 ISE® Luminary Leadership Award winner. ... the achievements of an outstanding leader and industry ... and contributions in advancing the information security industry. ...
(Date:10/20/2014)... D.C. (PRWEB) October 20, 2014 Zereana Jess-Huff, ... crowned Mrs. Maryland 2014 on a platform to think outside ... scars, and uses her position to raise awareness about women’s ... awareness for breast cancer. You say the color pink and ... I know for a fact that it has not been ...
(Date:10/20/2014)... My Clients Plus ( http://www.MyClientsPlus.com ) ... The new module enables easy administration and routing of ... care. , This application allows users such as Therapists ... a to-do item to a specific client, categorize tasks ... reoccurring reminders for follow-ups. It's designed to enable ...
(Date:10/20/2014)... AttorneyOne.com, a recognized authority on law, update the ... on Sit and Slim II . , The ... use Sit and Slim II because it contains Sibutramine ... weight loss product on various websites and possibly in some ... for safety reasons, can significantly increase blood pressure and/or pulse ...
Breaking Medicine News(10 mins):Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:My Clients Plus Announces New Workflow Management Software 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2
(Date:10/20/2014)... de octubre de 2014  PneumRx, Inc. ( ... la pulmonología intervencional, anunció hoy la conclusión de ... meses antes de lo programado. El Estudio Clínico RENEW ... de investigación (IDE) aprobada por la FDA (Administración ... espiral de reducción de volumen pulmonar PneumRx RePneu, ...
(Date:10/20/2014)... , Oct. 20, 2014  ResMed (NYSE: ... the ResMed Data Exchange program, a comprehensive suite ... equipment (HME) and other health care providers. ... access to critical patient information. It integrates valuable ... and U-Sleep™ patient management platforms with customers, in-house ...
(Date:10/20/2014)... 20, 2014  AnaptysBio, Inc., a leader in ... announced the appointment of Marco Londei , ... lead the preclinical and clinical development of AnaptysBio,s ... pleased to welcome Dr. Londei to AnaptysBio,s executive ... and Chief Executive Officer of AnaptysBio. "Dr. Londei,s ...
Breaking Medicine Technology:PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2
Cached News: